Patent to safely combine MDD and IVDD functionality into one unit is granted in Brazil
Brighter AB [publ], today announced that Brighter's patent for a safety mechanism when combining injection functionality which is regulated under MDD ("Medical Device Directive") and diagnostic technology which is regulated under IVDD ("In-Vitro Diagnostics Directive") into one unit is being granted in Brazil. The function means that the display of a drug delivery device (e.g. Actiste) is switched off while the user sets the dose, to make the user look at the dose setting and not at the display, which increases patient safety. The patent is an extension of Brighter's main patent and